Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

StressGen and Genzyme announce closing of joint venture

Aug. 8, 1997

Genzyme Transgenics' cancer vaccine elicits immune response in myeloma patients

Aug. 7, 1997

HemoCleanse submits 510(k) for ThermoChem-HT

Aug. 7, 1997

New agent for breast cancer in development at Zenyaku Kogyo

Aug. 7, 1997

Antiproliferative agents from Kirin Brewery

Aug. 6, 1997

Korean researchers isolate aminopeptidase inhibitors from microbial source

Aug. 6, 1997

Novel camptothecin analogues reported by Korean scientists

Aug. 6, 1997

KSA-based cancer vaccine in development

Aug. 5, 1997

Seven more marketing approvals announced for Campto

Aug. 4, 1997

Apoptosis Technology and BioChem Pharma to collaborate on anticancer agents

Aug. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...